Valuation: ChemoMetec A/S

Capitalization 5.45B 855M 730M 669M 632M 1.17B 81.81B 1.18B 7.96B 3.1B 38.82B 3.21B 3.14B 135B P/E ratio 2026 *
27.3x
P/E ratio 2027 * 24.1x
Enterprise value 5.08B 796M 680M 623M 589M 1.09B 76.18B 1.1B 7.42B 2.89B 36.15B 2.99B 2.92B 126B EV / Sales 2026 *
9.89x
EV / Sales 2027 * 8.84x
Free-Float
96.27%
Yield 2026 *
2.19%
Yield 2027 * 2.35%
1 day-2.25%
1 week-2.55%
Current month-2.06%
1 month+3.57%
3 months-22.31%
6 months-59.22%
Current year-54.41%
1 week 312.6
Extreme 312.6
330.6
1 month 298.6
Extreme 298.6
353.6
Current year 235.2
Extreme 235.2
732.5
1 year 235.2
Extreme 235.2
804
3 years 235.2
Extreme 235.2
804
5 years 235.2
Extreme 235.2
1,149
10 years 25.4
Extreme 25.4
1,149
Manager TitleAgeSince
Chief Executive Officer 33 12/03/2024
Director of Finance/CFO - 30/06/2024
Chief Tech/Sci/R&D Officer - 19/12/2023
Director TitleAgeSince
Director/Board Member 67 30/09/2013
Director/Board Member 64 30/09/2014
Director/Board Member 50 -
Change 5d. change 1-year change 3-years change Capi.($)
-2.25%-2.55%-37.38%-23.82% 876M
-0.06%-0.49%+8.96%+0.66% 12.7B
-0.08%-0.04%+10.43%+3.35% 9.35B
+0.29%+2.19%-1.21%-22.91% 5.58B
+1.03%+0.30%+51.42%+29.10% 5.48B
+2.71%+3.23%-14.42%+44.61% 4.88B
-0.94%-0.17%-16.54%-9.07% 4.39B
-5.97%-5.17% - - 3.34B
-1.15%+9.73%-0.22%-75.87% 2.12B
-0.18%-0.88%+6.16%-42.99% 1.66B
Average -0.68%+1.86%+0.80%-10.77% 5.04B
Weighted average by Cap. -0.21%+0.97%+6.82%-0.08%

Financials

2026 *2027 *
Net sales 514M 80.52M 68.77M 63.01M 59.57M 110M 7.71B 111M 750M 292M 3.66B 302M 296M 12.71B 568M 88.98M 75.99M 69.62M 65.82M 122M 8.52B 123M 829M 323M 4.04B 334M 327M 14.05B
Net income 200M 31.31M 26.74M 24.5M 23.16M 42.89M 3B 43.11M 292M 114M 1.42B 117M 115M 4.94B 227M 35.54M 30.35M 27.81M 26.29M 48.68M 3.4B 48.93M 331M 129M 1.61B 133M 131M 5.61B
Net Debt -375M -58.81M -50.22M -46.01M -43.5M -80.55M -5.63B -80.97M -548M -213M -2.67B -221M -216M -9.28B -433M -67.94M -58.02M -53.16M -50.25M -93.06M -6.5B -93.54M -633M -246M -3.09B -255M -250M -10.72B
Logo ChemoMetec A/S
Chemometec A/S is a Denmark-based company engaged in the development, manufacture and sale of analytical instruments used for quantitative analysis of cells in liquids. The Company’s activities are divided into three business areas: Instruments, which offers a range of NucleoCounter analytical instruments for counting mammalian, animal, yeast and sperm cells, as well as somatic cells in milk, among others; Consumables, which distributes disposable cassettes, solutions, reagents and slides; and Other, which is responsible for the partnership development in a number of research projects, among others. The Company’s analytical products are based on a technology, which combines fluorescence microscopy with digital imagery. Its customer portfolio comprises entities active primarily within pharmaceutical, food processing and agriculture industries. Furthermore, the Company is a parent of ChemoMetec USA Inc.
Employees
172
Date Price Change Volume
13/05/26 313.40 kr -2.25% 58,251
12/05/26 320.60 kr +1.46% 49,274
11/05/26 316.00 kr +0.38% 61,017
08/05/26 314.80 kr -2.30% 58,986
07/05/26 322.20 kr +0.19% 131,294
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
313.40DKK
Average target price
546.25DKK
Spread / Average Target
+74.30%

Quarterly revenue - Rate of surprise